{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T02:57:31Z","timestamp":1776913051753,"version":"3.51.2"},"reference-count":35,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.prp.2020.153036","type":"journal-article","created":{"date-parts":[[2020,5,28]],"date-time":"2020-05-28T20:27:05Z","timestamp":1590697625000},"page":"153036","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Analysis of multigene detection in patients with advanced lung adenocarcinoma using cytological specimens"],"prefix":"10.1016","volume":"216","author":[{"given":"Yang","family":"Ma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaokun","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2020.153036_bib0005","doi-asserted-by":"crossref","first-page":"4617","DOI":"10.1200\/JCO.2008.17.7162","article-title":"Chemotherapy in addition to supportive care improves survival in advanced non-small-cell lung cancer: a systematic review and metaanalysis of individual patient data from 16 randomized controlled trials","volume":"26","author":"Meta-Analyses Collaborative Group","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.prp.2020.153036_bib0010","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1200\/JCO.2005.00.992","article-title":"Mutations of the epidermal growth factor receptor gene predict prolonged survival after ge\ufb01tinib treatment in patients with non-smallcell lung cancer with postoperative recurrence","volume":"23","author":"Mitsudomi","year":"2005","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.prp.2020.153036_bib0015","first-page":"504","article-title":"Non-small cell lung cancer, version 5.2017, NCCN clinical practice guidelines in oncology[J]","volume":"15","author":"Ettinger","year":"2017","journal-title":"J. Compr. Canc. Netw."},{"key":"10.1016\/j.prp.2020.153036_bib0020","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/1759-7714.12932","article-title":"Detecting EGFR mutations and ALK\/ROS1 rearrangements in non-small cell lung cancer using malignant pleural effusion samples","volume":"10","author":"Yao","year":"2019","journal-title":"Thorac. Cancer"},{"issue":"5","key":"10.1016\/j.prp.2020.153036_bib0025","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1158\/1078-0432.CCR-13-0699","article-title":"Lung cancers with concomitant EGFR mutations and ALK rearrangements: diverse responses to EGFR\u2010TKI and crizotinib in relation to diverse receptors phosphorylation","volume":"20","author":"Yang","year":"2014","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.prp.2020.153036_bib0030","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1093\/annonc\/mdu530","article-title":"Concomitant ALK translocation and EGFR mutation in lung cancer: a comparison of direct sequencing and sensitive assays and the impact on responsiveness to tyrosine kinase inhibitor","volume":"26","author":"Won","year":"2015","journal-title":"Ann. Oncol."},{"issue":"40","key":"10.1016\/j.prp.2020.153036_bib0035","doi-asserted-by":"crossref","first-page":"65185","DOI":"10.18632\/oncotarget.11218","article-title":"Clinical outcomes of advanced non\u2010small\u2010cell lung cancer patients with EGFR mutation,ALK rearrangement and EGFR\/ALK co\u2010alterations","volume":"7","author":"Lou","year":"2016","journal-title":"Oncotarget"},{"issue":"9","key":"10.1016\/j.prp.2020.153036_bib0040","doi-asserted-by":"crossref","first-page":"6605","DOI":"10.2147\/OTT.S121923","article-title":"Effective treatment with icotinib in lung adenocarcinoma with EGFR and ALK co\u2010alterations and brain metastasis","volume":"26","author":"Ye","year":"2016","journal-title":"Onco. Ther."},{"issue":"3","key":"10.1016\/j.prp.2020.153036_bib0045","doi-asserted-by":"crossref","first-page":"320","DOI":"10.2353\/jmoldx.2007.060182","article-title":"Mucinous differentiation correlates with absence of EGFR mutation and presence of KRAS mutation in lung adenocarcinomas with bronchioloalveolar features","volume":"9","author":"Finberg","year":"2007","journal-title":"J. Mol. Diagn."},{"issue":"4","key":"10.1016\/j.prp.2020.153036_bib0050","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jtho.2016.12.003","article-title":"Clinical outcome of ALK\u2010Positive non\u2010small cell lung Cancer (NSCLC) patients with de novo EGFR or KRAS Co\u2010mutations receiving tyrosine kinase inhibitors (TKIs)","volume":"12","author":"Schmid","year":"2017","journal-title":"J. Thorac. Oncol."},{"issue":"3","key":"10.1016\/j.prp.2020.153036_bib0055","doi-asserted-by":"crossref","first-page":"320","DOI":"10.2353\/jmoldx.2007.060182","article-title":"Mucinous differentiation correlates with absence of EGFR mutation and presence of KRAS mutation in lung adenocarcinomas with bronchioloalveolar features","volume":"9","author":"Finberg","year":"2007","journal-title":"J. Mol. Diagn."},{"issue":"1","key":"10.1016\/j.prp.2020.153036_bib0060","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.cllc.2015.08.001","article-title":"EGFR and KRAS mutations in ALK\u2010positive lung adenocarcinomas: biological and clinical effect","volume":"17","author":"Sahnane","year":"2016","journal-title":"Clin. Lung Cancer"},{"issue":"1","key":"10.1016\/j.prp.2020.153036_bib0065","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1093\/annonc\/mdt495","article-title":"Clinicopathological features of nonsmall cell lung carcinomas with BRAF mutations","volume":"25","author":"Kinno","year":"2014","journal-title":"Ann. Oncol."},{"issue":"1","key":"10.1016\/j.prp.2020.153036_bib0070","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1200\/JCO.1999.17.1.380","article-title":"RET proto-oncogene in the development of human cancer","volume":"17","author":"Eng","year":"1999","journal-title":"J. Clin. Oncol."},{"issue":"7153","key":"10.1016\/j.prp.2020.153036_bib0075","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nature05945","article-title":"Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer","volume":"448","author":"Soda","year":"2007","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.prp.2020.153036_bib0080","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/nm.2644","article-title":"KIF5B-RET fusions in lung adenocarcinoma","volume":"18","author":"Kohno","year":"2012","journal-title":"Nat. Med."},{"issue":"35","key":"10.1016\/j.prp.2020.153036_bib0085","doi-asserted-by":"crossref","first-page":"4352","DOI":"10.1200\/JCO.2012.44.1477","article-title":"RET fusions define a unique molecular and clinicopathologic subtype of non-small-cell lung cancer","volume":"30","author":"Wang","year":"2012","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.prp.2020.153036_bib0090","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.lungcan.2006.07.006","article-title":"PIK3CA mutation status in Japanese lung cancer patients","volume":"54","author":"Kawano","year":"2006","journal-title":"Lung Cancer"},{"issue":"17","key":"10.1016\/j.prp.2020.153036_bib0095","doi-asserted-by":"crossref","first-page":"6913","DOI":"10.1158\/0008-5472.CAN-07-5084","article-title":"PIK3CA mutations and copy number gains in human lung cancers","volume":"68","author":"Yamamoto","year":"2008","journal-title":"Cancer Res."},{"issue":"24","key":"10.1016\/j.prp.2020.153036_bib0100","doi-asserted-by":"crossref","first-page":"6771","DOI":"10.1158\/1078-0432.CCR-12-2347","article-title":"Phosphoinositide 3-kinase (PI3K) pathway alterations are associated with histologic subtypes and are predictive of sensitivity to PI3K inhibitors in lung cancer preclinical models","volume":"18","author":"Spoerke","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.prp.2020.153036_bib0105","first-page":"497","article-title":"PIK3CA gene mutation associated with poor prognosis of lung adenocarcinoma","volume":"6","author":"Zhang","year":"2013","journal-title":"Onco. Ther."},{"issue":"2","key":"10.1016\/j.prp.2020.153036_bib0110","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1158\/1535-7163.MCT-11-0692","article-title":"Coexistence of PIK3CA and other oncogene mutations in lung adenocarcinoma-rationale for comprehensive mutation profiling","volume":"11","author":"Chaft","year":"2012","journal-title":"Mol. Cancer Ther."},{"issue":"3","key":"10.1016\/j.prp.2020.153036_bib0115","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1200\/JCO.2011.36.1360","article-title":"Phase I, dose-escalation study of BKM120, an oral pan-class I PI3K inhibitor, in patients with advanced solid tumors","volume":"30","author":"Bendell","year":"2012","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.prp.2020.153036_bib0120","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S1470-2045(17)30064-5","article-title":"Buparlisib and paclitaxel in patients with platinum-pretreated recurrent or metastatic squamous cell carcinoma of the head and neck (BERIL-1): a randomised, double-blind, placebo-controlled phase 2 trial","volume":"18","author":"Soulieres","year":"2017","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.prp.2020.153036_bib0125","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1158\/2159-8290.CD-14-1467","article-title":"Response to MET inhibitors in patients with stage IV lung adenocarcinomas harboring MET mutations causing exon 14 skipping","volume":"5","author":"Paik","year":"2015","journal-title":"Cancer Discov."},{"key":"10.1016\/j.prp.2020.153036_bib0130","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.lungcan.2016.12.001","article-title":"A comprehensive analysis of clinical outcomes in lung cancer patients harboring a MET exon 14 skipping mutation compared to other driver mutations in an East Asian population","volume":"103","author":"Gow","year":"2017","journal-title":"Lung Cancer"},{"key":"10.1016\/j.prp.2020.153036_bib0135","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1158\/1078-0432.CCR-15-2061","article-title":"MET amplification and exon 14 splice site mutation define unique molecular subgroups of non-small cell lung carcinoma with poor prognosis","volume":"22","author":"Tong","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.prp.2020.153036_bib0140","doi-asserted-by":"crossref","first-page":"41691","DOI":"10.18632\/oncotarget.9541","article-title":"MET exon 14 skipping defines a unique molecular class of non-small cell lung cancer","volume":"7","author":"Zheng","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.prp.2020.153036_bib0145","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.jtho.2017.04.031","article-title":"MET exon 14 skipping mutations in lung adenocarcinoma: clinicopathologic implications and prognostic values","volume":"12","author":"Lee","year":"2017","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.prp.2020.153036_bib0150","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1158\/2159-8290.CD-15-0285","article-title":"Activation of MET via diverse exon 14 splicing alterations occurs in multiple tumor types and confers clinical sensitivity to MET inhibitors","volume":"5","author":"Frampton","year":"2015","journal-title":"Cancer Discov."},{"key":"10.1016\/j.prp.2020.153036_bib0155","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.cllc.2015.01.009","article-title":"Response to crizotinib in a patient with lung adenocarcinoma harboring a MET splice site mutation","volume":"16","author":"Jenkins","year":"2015","journal-title":"Clin. Lung Cancer"},{"key":"10.1016\/j.prp.2020.153036_bib0160","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1200\/JCO.2015.64.2777","article-title":"Impaired c-Met receptor degradation mediated by MET exon 14 mutations in non-small-cell lung cancer","volume":"34","author":"Awad","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.prp.2020.153036_bib0165","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.1158\/1078-0432.CCR-13-0318","article-title":"ALK rearrangements are mutually exclusive with mutations in EGFR or KRAS: an analysis of 1,683 patients with nonsmall cell lung cancer","volume":"19","author":"Gainor","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.prp.2020.153036_bib0170","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1097\/JTO.0000000000000516","article-title":"Multiinstitutional oncogenic driver mutation analysis in lung adenocarcinoma: the lung Cancer mutation consortium experience","volume":"10","author":"Sholl","year":"2015","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.prp.2020.153036_bib0175","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1158\/2159-8290.CD-17-0151","article-title":"AACR project genie:powering precision medicine through an international consortium","volume":"7","author":"Sweeney","year":"2017","journal-title":"Cancer Discov."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033820305318?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033820305318?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T06:42:28Z","timestamp":1759732948000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033820305318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":35,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S0344033820305318"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2020.153036","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analysis of multigene detection in patients with advanced lung adenocarcinoma using cytological specimens","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2020.153036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"153036"}}